Healthcare & Life Sciences
GPN Vaccines
series-b
series-b
Stage
1
Investors
About
Developing a universal vaccine targeting pneumococcus (Streptococcus pneumoniae) to provide broad protection against the pathogen.
Explore GPN Vaccines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.